How often do general practitioners use placebos and non-specific interventions? Systematic review and meta-analysis of surveys

• Published in: PloS one 2018-08, Vol.13 (8), p.e0202211-e0202211
• Main Authors: Linde, Klaus, Atmann, Oxana, Meissner, Karin, Schneider, Antonius, Meister, Ramona, Kriston, Levente, Werner, Christoph
• Format: Article
• Language: English
• Subjects: Analysis; Antibiotics; Biology and Life Sciences; Careers; Clinical medicine; Clinical trials; Common cold; Cross-Sectional Studies; Family physicians; General Practitioners; Health aspects; Humans; Infections; Intervention; Medical personnel; Medicine; Medicine and Health Sciences; Meta-analysis; Methods; People and Places; Physical Sciences; Physicians; Placebo Effect; Placebos; Placebos - therapeutic use; Polls & surveys; Practice; Practice Patterns, Physicians; Primary care; Research and Analysis Methods; Social Sciences; Surveys; Surveys and Questionnaires; Systematic review; Viral infections
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0202211

In a systematic review and meta-analysis we summarize the available evidence on how frequently general practitioners/family physicians (GPs) use pure placebos (e.g., placebo pills) and non-specific therapies (sometimes referred to as impure placebos; e.g., antibiotics for common cold). We searched Medline, PubMed and SCOPUS up to July 2018 to identify cross-sectional quantitative surveys among GPs. Outcomes of primary interest were the percentages of GPs having used any placebo, pure placebos or non-specific therapies at least once in their career, at least once in the last year, at least monthly or at least weekly. Outcomes were described as proportions and pooled with random-effects meta-analysis. Of 674 publications, 16 studies from 13 countries with a total of 2.981 participating GPs (range 27 to 783) met the inclusion criteria. The percentage of GPs having used any form of placebo at least once in their career ranged from 29% to 97%, in the last year at least once from 46% to 95%, at least monthly from 15% to 89%, and at least weekly from 1% to 75%. The use of non-specific therapies by far outnumbered the use of pure placebo. For example, the proportion of GPs using pure placebos at least monthly varied between 2% and 15% compared to 53% and 89% for non-specific therapies; use at least weekly varied between 1% and 3% for pure placebos and between 16% and 75% for non-specific therapies. Besides eliciting placebos effects, many other reasons related to patient expectations, demands and medical problems were reported as reasons for applying placebo interventions. High prevalence estimates of placebo use among GPs are mainly driven by the frequent use of non-specific therapies; pure placebos are used rarely. The interpretation of our quantitative findings is complicated by the diversity of definitions and survey methods.